WHO ICTRP trial
Efficacy and safety of ECIWEP protein injection in the treatment of amyotrophic…
ChiCTR2300074923 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300074923 |
|---|---|
| Public title | Efficacy and safety of ECIWEP protein injection in the treatment of amyotrophic lateral sclerosis: a single-arm, open-label, single-center clinical trial |
| Scientific title | Efficacy and safety of ECIWEP protein injection in the treatment of amyotrophic lateral sclerosis: a single-arm, open-label, single-center clinical trial |
| Primary sponsor | Tsinghua University Yuquan Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Treatment study |
| Countries | CHINA |
| Conditions | Amyotrophic lateral sclerosis |
| Interventions | therapy:ECIWEP THERAPY |
| Registration date | Aug 21, 2023 |
| Target size | therapy:8 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: